Post-transplant Lymphoproliferative Disease
3 clinical trials · Condition
◉ Watch Post-transplant Lymphoproliferative Disease
| Record | Firm | Date |
|---|---|---|
| Immunotherapy With Tacrolimus Resistant EBV CTL for Lymphoproliferative Disease After Solid Organ Transplant (NCT03131934) | University College, London | 2019-05-31 |
| Bortezomib Plus Rituximab for EBV+ PTLD (NCT01058239) | Massachusetts General Hospital | 2011-11-01 |
| Chemotherapy for Relapsed Epstein Barr Virus Associated Lymphoma (NCT01964755) | University of Miami | 2009-04-21 |
Track Post-transplant Lymphoproliferative Disease automatically
Every clearance here is in the API, with alerts when new ones post.